EMA/PE/0000181174 - paediatric investigation plan

Dasiglucagon

Key facts

• Invented name:
  Zegalogue
• Active substance:
  Dasiglucagon
• Therapeutic area:
  Endocrine disorders
• Decision number:
  EMA/PE/0000181174
• PIP number:
  EMA/PE/0000181174
• Pharmaceutical form(s):
  Solution for injection
• Condition(s) / indication(s):
  Treatment of hypoglycaemia
• Route(s) of administration:
  Subcutaneous use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  03/01/2025
• Compliance check done:
  Nein

Decision

EMA/PE/0000181174 : EMA decision of 3 January 2025 on the acceptance of a modification of an agreed paediatric investigation plan for dasiglucagon (Zegalogue)

Adopted Reference Number: EMADOC-1700519818-1809705